|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | A61K 31/444 | (2006.01) |
| A61P 25/06 | (2006.01) |
| (11) | Number of the document | 3846810 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19773583.0 |
| Date of filing the European patent application | 2019-09-03 | |
| (97) | Date of publication of the European application | 2021-07-14 |
| (45) | Date of publication and mention of the grant of the patent | 2023-10-18 |
| (46) | Date of publication of the claims translation | 2024-01-10 |
| (86) | Number | PCT/US2019/049340 |
| Date | 2019-09-03 |
| (87) | Number | WO 2020/051137 |
| Date | 2020-03-12 |
| (30) | Number | Date | Country code |
| 201862726585 P | 2018-09-04 | US |
| (72) |
CONLEY, Robert Russell , US
DAVAR, Gudarz , US
JOHNSON, Kirk Willis , US
|
| (73) |
Eli Lilly and Company ,
Lilly Corporate Center, Indianapolis, IN 46285,
US
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Ilgai besitęsiantis lasmiditano dozavimas kasnakt migrenos profilaktikai |
| CHRONIC NIGHTLY DOSING OF LASMIDITAN FOR MIGRAINE PREVENTION |
| Payment date | Validity (years) | Amount | |
| 2024-08-20 | 6 | 139.00 EUR |
| 2025-09-03 |